Today is Vascular Day Dr Arvind Kohli 6th August in India marks Vascular Day, a time dedicated to raising awareness about the ...

Heartflow has pumped up its IPO ambitions, raising its proposal into the vicinity of $300 million. | After first pricing its ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Q2 2025 Earnings Call Transcript August 5, 2025 InspireMD, Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, ...

In patients with type 2 diabetes and CVD, the GIP/GLP-1 agonist was as good as the older drug, and possibly better in some ...

Among midlife women, only about 21% reached ideal cardiovascular health scores at baseline, per the American Heart ...

AngioDynamics (Nasdaq:ANGO) announced today that it enrolled the first patient in a randomized study of its Auryon ...

The Neurosciences Institute at The George Washington University Hospital is home to some of the region’s most advanced technological equipment, including neurointerventional biplane technology.

Q2 2025 earnings insights, including its FDA-approved CGuard Prime launch, revenue growth plans, strong financial backing, ...

Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...

AngioDynamics, Inc. announced enrollment of the first patient in the AMBITION BTK study of the Auryon atherectomy system.